Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 30

Results For "Chairman"

822 News Found

Jupiter Life Line Hospitals’ IPO to open on Sept. 6
News | September 02, 2023

Jupiter Life Line Hospitals’ IPO to open on Sept. 6

Sets price band at ?695 to ?735 per Equity Share


Elekta and IAEA partner to improve access to cancer care in underserved countries
Healthcare | September 01, 2023

Elekta and IAEA partner to improve access to cancer care in underserved countries

Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden


Pfizer and BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID-19 vaccine
News | September 01, 2023

Pfizer and BioNTech receive positive CHMP opinion for Omicron XBB.1.5-adapted COVID-19 vaccine

The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age and older


Mankind Pharma launches 120 premium DMF quality drugs for Indian Patients
News | August 30, 2023

Mankind Pharma launches 120 premium DMF quality drugs for Indian Patients

Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre


Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation
People | August 29, 2023

Bayer appoints Dr. Juergen Eckhardt as new Head of Pharmaceuticals Business Development & Licensing/Open Innovation

Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer


Apollo’s Apollo Connect program bets big on expanding access and elevating care
Digitisation | August 29, 2023

Apollo’s Apollo Connect program bets big on expanding access and elevating care

Aims to build the largest connected healthcare ecosystem in India


Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders
Diagnostic Center | August 28, 2023

Zydus to present on ZYIL1 at the International Congress of Parkinson's Disease and Movement Disorders

In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers


Lynparza plus abi/pred approved in Japan for treatment of prostate cancer
Drug Approval | August 25, 2023

Lynparza plus abi/pred approved in Japan for treatment of prostate cancer

First PARP inhibitor approved in Japan to demonstrate clinically meaningful benefits in combination with a new hormonal agent